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Genetic Risk for Aortic Aneurysm
in Adolescent Idiopathic Scoliosis
Gabe Haller, PhD, David M. Alvarado, PhD, Marcia C. Willing, MD, Alan C. Braverman, MD, Keith H. Bridwell, MD,
Michael Kelly, MD, Lawrence G. Lenke, MD, Scott J. Luhmann, MD, Christina A. Gurnett, MD, PhD, and Matthew B. Dobbs, MD
Investigation performed at the Departments of Orthopaedic Surgery, Pediatrics, Cardiology, and Neurology, Washington University, St. Louis, Missouri
Background: Scoliosis is a feature of several genetic disorders that are also associated with aortic aneurysm, including
Marfan syndrome, Loeys-Dietz syndrome, and type-IV Ehlers-Danlos syndrome. Life-threatening complications of aortic
aneurysm can be decreased through early diagnosis. Genetic screening formutations in populations at risk, such as patients
with adolescent idiopathic scoliosis, may improve recognition of these disorders.
Methods: The coding regions of ﬁve clinically actionable genes associated with scoliosis (COL3A1, FBN1, TGFBR1,
TGFBR2, and SMAD3) and aortic aneurysm were sequenced in 343 adolescent idiopathic scoliosis cases. Gene variants
that hadminor allele frequencies of <0.0001 or were present in human diseasemutation databases were identiﬁed. Variants
were classiﬁed as pathogenic, likely pathogenic, or variants of unknown signiﬁcance.
Results: Pathogenic or likely pathogenic mutations were identiﬁed in 0.9% (three) of 343 adolescent idiopathic scoliosis
cases. Two patients had pathogenic SMAD3 nonsense mutations consistent with type-III Loeys-Dietz syndrome and one
patient had a pathogenic FBN1 mutation with subsequent conﬁrmation of Marfan syndrome. Variants of unknown signiﬁ-
cance in COL3A1 and FBN1 were identiﬁed in 5.0% (seventeen) of 343 adolescent idiopathic scoliosis cases. Six FBN1
variants were previously reported in patients with Marfan syndrome, yet were considered variants of unknown signiﬁcance
based on the level of evidence. Variants of unknown signiﬁcance occurred most frequently in FBN1 and were associated
with greater curve severity, systemic features of Marfan syndrome, and joint hypermobility.
Conclusions: Clinically actionable pathogenic mutations in genes associated with adolescent idiopathic scoliosis and
aortic aneurysm are rare in patients with adolescent idiopathic scoliosis who are not suspected of having these disorders,
although variants of unknown signiﬁcance are relatively common.
Clinical Relevance: Routine genetic screening of all patients with adolescent idiopathic scoliosis for mutations in
clinically actionable aortic aneurysm disease genes is not recommended on the basis of the high frequency of variants of
unknown signiﬁcance. Clinical evaluation and family history should heighten indications for genetic referral and testing.
A
dolescent idiopathic scoliosis is a diagnosis of exclusion.
Scoliosis is a feature of many genetic disorders, including
several that may present with mild phenotypes or in-
complete penetrance of typical manifestations despite known
disease-causing mutations1. Diagnosis during childhood or ado-
lescence, when most children with adolescent idiopathic scoliosis
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are evaluated, is also problematic for disorders that may not
manifest until adulthood2,3. Although positive family histories
can aid the diagnosis of some disorders, many individuals do
not know their family history, or mutations may arise de novo,
making family history less informative.
Marfan syndrome, Loeys-Dietz syndrome, and type-IV
Ehlers-Danlos syndromemay be associated with scoliosis4-6 and
are important to diagnose because of the high risk of life-
threatening aortic aneurysm. Because treatment can prevent the
life-threatening consequences of aortic aneurysm, the American
College of Medical Genetics and Genomics has included these
disease genes among the ﬁfty-six genes considered medically
actionable7. Reporting of results for these genes is therefore rec-
ommended, even when mutations are found incidentally during
exome sequencing for unrelated disorders. Mutations in ﬁve
clinically actionable genes, COL3A1 (type-IV Ehlers-Danlos
syndrome)8, FBN1 (Marfan syndrome)9, TGFBR1 (type-I Loeys-
Dietz syndrome),TGFBR2 (type-II Loeys-Dietz syndrome)10, and
SMAD3 (type-III Loeys-Dietz syndrome) (Table I)11, are con-
sidered here because they have a higher-than-average risk of
scoliosis and may be difﬁcult to diagnose clinically (Table I).
Materials and Methods
Patient Samples
Patients with adolescent idiopathic scoliosis were recruited from St. LouisChildren’s Hospital and St. Louis Shriners Hospital for Children. This study
was approved by the institutional review board and all patients and/or parents
provided informed consent. All patients had spinal curves of >10 and of
unknown etiology, althoughmost patients had curves of 40 to 50. Patients with
developmental delay, multiple congenital anomalies, or known or suspected
underlying medical disorders, including Marfan syndrome or Ehlers-Danlos
syndrome, were excluded from the study. The systemic features of Marfan syn-
drome and joint hypermobility were evaluated in some patients with use of the
Ghent criteria
2
and the Beighton scoring system
12
. Patients were recontacted after
potentially disease-causing variants were discovered as part of this research study
and were referred to clinical geneticists at St. Louis Children’s Hospital and
St. Louis Shriners Hospital for Children. Echocardiograms and ophthalmological
evaluations were often ordered as part of the clinical genetics evaluations.
Sequencing and Analysis
Exome sequencing was performed on 343 unrelated patients with adolescent
idiopathic scoliosis. All sequencing reads were aligned to the hg19 human ref-
erence sequence (Build 37) with use of Novoalign software (Novocraft, Selangor,
Malaysia). Variant calling and annotation were completed with use of SAMtools
(http://samtools.sourceforge.net) and SeattleSeq Annotation (University of
Washington, Seattle, Washington). All variants were deﬁned as extremely rare if
they were present at minor allele frequencies of <0.0001 in the NHLBI (Na-
tional Heart, Lung, and Blood Institute) GO (Grand Opportunity) Exome
Sequencing Project (n = 6503)
13
. Analysis was restricted to variants altering the
coding sequence (nonsense, splice-site, missense, and insertion or deletion
variants). All variants were validated by Sanger sequencing.
Source of Funding
Two authors of this study (M.B.D. and C.A.G.) received grants from the Shriners
Hospital for Children, the Marfan Foundation, the National Institutes of Health
(NIH), the Children’s Discovery Institute of St. Louis Children’s Hospital and
Washington University School of Medicine, and the University of Missouri Spinal
Cord Injuries Research Program. Funds were used to pay for sequencing, analysis,
and salaries.
Results
We identiﬁed twenty-one extremely rare variants in threegenes associated with both scoliosis and aortic aneurysm
(COL3A1, FBN1, and SMAD3) in a screen of 343 patients with
adolescent idiopathic scoliosis (Table II). No extremely rare
variants were identiﬁed in TGFBR1 or TGFBR2.
Two pathogenic variants were identiﬁed in SMAD3, the
gene responsible for type-III Loeys-Dietz syndrome, which is
TABLE I Clinically Actionable Disease Genes Associated with Scoliosis and Aortic Aneurysm





Arterial dissection, rupture, or aneurysm;
bowel rupture; pregnancy complications
(uterine rupture); clubfoot; hip dysplasia;
thin, translucent skin; easy bruising; facial
features
1:200,00028
FBN1 Nonsense, missense Marfan syndrome Aortic aneurysm, joint hypermobility, tall
stature, long limbs, pectus deformity, lens
dislocation, glaucoma, cataract, facial
features
1:5000 to 10,00029
TGFBR1 Missense Type-I Loeys-Dietz
syndrome
Aortic aneurysm, arterial tortuosity, atrial
septal defect, bicuspid aortic valve, joint
hypermobility, long limbs, biﬁd uvula or




TGFBR2 Missense, nonsense Type-II Loeys-Dietz
syndrome
Vascular (aortic aneurysm, arterial
tortuosity), biﬁd uvula, translucent skin,
velvety skin
Unknown30
SMAD3 Missense, nonsense Type-III Loeys-Dietz
syndrome
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also known as the aortic aneurysm-osteoarthritis syndrome11.
Both SMAD3mutations are predicted to result in loss of function,
with a loss of the transcription start site (p.Met1Thr) in individual
6234001 and a premature termination codon (p.Ser161*) in in-
dividual 6281001. Loss of function mutation is one of the most
common types of mutation identiﬁed in type-III Loeys-Dietz
syndrome11,14,15. Neither SMAD3 mutation had previously been
reported. The proband carrying the SMAD3 p.Met1Thr mutation
had an 80 right thoracic curve that failed bracing and was sur-
gically treated. He was evaluated by the clinical genetics team at
the age of fourteen years, and, on the basis of clinical examination,
there was no suspicion for a diagnosis of type-III Loeys-Dietz
syndrome or other connective tissue disorder. His height was
173.5 cm (75th percentile) and his weight was 55.3 kg (97th
percentile). His facial features revealed a normal uvula and absent
hypertelorism. He had a normal echocardiogram at the age of
fourteen years. His maternal grandfather had a history of aortic
aneurysm and the proband’smother, who also had the pathogenic
SMAD3 p.Met1Thr mutation, had bilateral knee arthritis diag-
nosed at the age of forty-two years.
The second patient with adolescent idiopathic scoliosis
harboring a pathogenic SMAD3 loss of function mutation di-
agnostic of type-III Loeys-Dietz syndrome (p.Ser161*) presented
with a 70 right thoracic curve. Her height was 176 cm (97th
percentile) and her weight was 61 kg (78th percentile). She had
knee pain as a child, but was otherwise healthy. Her examination
did not reveal any evidence for a connective tissue disorder ex-
cept skin stria. There was no family history of aortic aneurysm,
heart disease, or arthritis.
Fourteen extremely rare variants in FBN1 were identiﬁed in
this cohort of 343 patients, and one was determined to be patho-
genic. Although six variants were previously reported in patients
withMarfan syndrome orMarfan-like phenotypes and are listed in
the Universal Mutation Database16, we determined that only FBN1
p.Ile2585Thr should be considered pathogenic. FBN1 p.Ile2585Thr
was previously reported in multiple patients with Marfan syn-
drome16-18 andwas absent frommore than 60,000 individuals in the
Exome Aggregation Consortium (ExAC) database19. Therefore,
according to the variant classiﬁcation criteria of Dorschner et al.,
the p.Ile2585Thr mutation is pathogenic because its allele fre-
quency is below the incidence of Marfan syndrome, it is present in
at least three unrelated affected individuals, and it segregates with
disease20. The proband with adolescent idiopathic scoliosis with
the p.Ile2585Thr mutation had a 93 right thoracic curve. She was
subsequently diagnosed with Marfan syndrome after clinical ge-
netics and echocardiogram evaluations. She had an elevated Ghent
systemic feature score (10 points of 22 points total) and a dilated
aortic root (a standard deviation of12.6), consistent with Marfan
syndrome. There was no family history of Marfan syndrome
or aortic aneurysm. Therefore, overall, we detected two SMAD3
pathogenic variants and one FBN1 pathogenic variant in our
cohort of 343 adolescent idiopathic scoliosis cases, resulting in
a yield of 0.9% (three of 343 cases).
Five additional FBN1 variants in our patients with ado-
lescent idiopathic scoliosis were previously reported in patients
with Marfan syndrome or Marfan-like phenotypes16, but ac-
cording to the Dorschner criteria20, these missense variants did
not meet the criteria to be considered as pathogenic because they
had not been reported in at least three individuals with Marfan
syndrome and did not segregate with disease in at least one
family. Therefore, all ﬁve of these FBN1 variants were considered
variants of unknown signiﬁcance. The FBN1 p.Met1576Thr
mutation was present in ten of 122,930 control alleles and
p.Leu1405Arg was present in six of 122,898 control alleles19. Al-
though these frequencies were less than the incidence of Marfan
syndrome (estimated to be 1:5000 to 10,000), the relatively
high frequency in ExAC suggests the possibility that these
variants may have been benign polymorphisms. However, the
p.Met1576Thr variant was highly enriched in our adolescent
idiopathic scoliosis cohort because it was identiﬁed in three of
343 adolescent idiopathic scoliosis cases. Two patients with ado-
lescent idiopathic scoliosis with the FBN1 p.Met1576Thr variant
underwent clinical genetics evaluations and had a normal range
of Ghent systemic features (4 to 5 points) and normal echo-
cardiograms and ophthalmological evaluations. Although they
were both tall (height, ‡89th percentile), they did not meet
clinical criteria for Marfan syndrome when evaluated at the
ages of nineteen and twenty years2. There was a family history
of tall stature, but no aortic aneurysm or scoliosis. Because
the p.Met1576Thr variant had previously been described in two
patients with isolated aortic dilation17,21, regular echocardiogram
evaluations were recommended for our patients with adolescent
idiopathic scoliosis with the p.Met1576Thr variant until further
data established its clinical importance. The FBN1 p.Leu1405Arg
variant was seen in a single patient with adolescent idiopathic
scoliosis, who was not found to have a dilated aorta or to meet
criteria for Marfan syndrome after evaluation by a medical ge-
neticist. She also had tall stature (91st percentile). This variant
was also present in her brother, with pectus excavatum and mild
scoliosis, and in her mother; both had normal echocardiograms.
Eight additional FBN1 rare variants of unknown signiﬁ-
cance that had not previously been associated with Marfan
syndromewere identiﬁed in adolescent idiopathic scoliosis cases.
Four patients were evaluated by a medical geneticist, and none
had a family history of Marfan syndrome or met criteria for
Marfan syndrome. However, as a group, patients with adolescent
idiopathic scoliosis with FBN1 variants had greater spinal curve
severity and higher Ghent systemic feature scores and Beighton
joint hypermobility scores compared with patients with ado-
lescent idiopathic scoliosis without variants in FBN1 (Table III).
These patients were also taller, but this was not signiﬁcant (p =
0.15). No differences in sex, weight, or family history were noted.
Three variants of unknown signiﬁcance were identiﬁed in
COL3A1, the gene responsible for type-IV Ehlers-Danlos syn-
drome. Although the vast majority of mutations in COL3A1 in
Ehlers-Danlos syndrome consist of splice-site, nonsense, or mis-
sense mutations resulting in glycine substitutions within the triple
helical domain6, these three novel missense variants resulted in
non-glycine amino acid substitutions. Because non-glycine amino
acid substitutions are rare causes of type-IV Ehlers-Danlos syn-
drome, the signiﬁcance of these mutations was unknown. None
underwent clinical genetic evaluation.
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Overall, genetic variants of unknown signiﬁcance in FBN1
were identiﬁed in fourteen adolescent idiopathic scoliosis cases
and variants of unknown signiﬁcance inCOL3A1were identiﬁed
in three adolescent idiopathic scoliosis cases, resulting in a 5.0%
(seventeen of 343) frequency of variants of unknown signiﬁ-
cance in our adolescent idiopathic scoliosis cases screened for
mutations in just ﬁve genes.
Discussion
This study reveals the complexity of genetic screening formutations in ﬁve clinically actionable genes associated with
aortic aneurysm in an adolescent idiopathic scoliosis population.
Despite diagnosing 0.9% of patients having adolescent idiopathic
scoliosis with either type-III Loeys-Dietz syndrome or Marfan
syndrome, a much larger number of patients had variants of
unknown signiﬁcance in these genes, leaving the clinician and the
patient in a precarious diagnostic dilemma. Although early di-
agnosis of Marfan syndrome and related disorders is important
because lifestyle modiﬁcations, regular echocardiographic eval-
uations, pharmacological treatments, and prophylactic surgical
procedures can substantially improve outcomes and lifespan22,
the lack of clinical information about so many variants will un-
doubtedly lead to additional, and often unnecessary, cost and
anxiety. Universal genetic screening of these ﬁve genes in a gen-
eral adolescent idiopathic scoliosis population may eventually
play a role in disease diagnosis, but the large number of variants
of unknown signiﬁcance reduces its current clinical utility.
In this study, two unrelated patients with adolescent idio-
pathic scoliosis were diagnosed with type-III Loeys-Dietz syn-
drome, a disorder whose associated craniofacial, skeletal, and
cutaneous abnormalitiesmay bemild11. The distinguishing feature
of type-III Loeys-Dietz syndrome is the presence of early-onset
arthritis, most often affecting the knees, spine, and thumb base at
a mean age of forty-two years, although it can be present in
childhood11. However, diagnosis is critical because aneurysms
occur in >90%of SMAD3 genemutation carriers15. Because of the
lifelong risk of aneurysm, our patients with adolescent idiopathic
scoliosis whowere diagnosedwith type-III Loeys-Dietz syndrome,
despite having normal echocardiograms, will need continued
surveillance. Compared with type-I Loeys-Dietz syndrome (due
TABLE II Rare Genetic Variants in COL3A1, FBN1, and SMAD3 Identiﬁed in Adolescent Idiopathic Scoliosis Cases† 






ExAC Database Sex Curve‡ Height§ Weight§
COL3A1
6294001 chr2:189856935 G > A R326Q 1 of 122,932 F 69 7 67
6292001 chr2:189873814 C > G N1230K F 48 38 25
6388001 chr2:189876375 A > G K1426E F 50 93 96
FBN1
6128001 chr15:48902952 T > A I107L F 84 20 21
6340001 chr15:48826300 T > G N280T M 48 >99 99
6377001 chr15:48795990 T > G N703H F 50 57 62
6623001 chr15:48791223 G > T A709E F 85 93 >99
6623001 chr15:48791224 C > T A709T F 85 93 >99
6683001 chr15:48787732 T > C P825A 1 of 122,446 F 90 66 44
6556001 chr15:48779275 C > T V1197I 6 of 122,898 F 77 38 95
6226001 chr15:48764870 A > C L1405R 6 of 122,898 F 97 91 85
6272001 chr15:48760155 A > G M1576T 10 of 122,930 F 90 21 40
6418001 chr15:48760155 A > G M1576T 10 of 122,930 F 65 >99 87
6442001 chr15:48760155 A > G M1576T 10 of 122,930 F 35 89 89
6320001 chr15:48736768 C > T G2003R F 66 7 30
6111001 chr15:48725128 T > A Y2225F M 95 93 86
6386001 chr15:48712949 A > G I2585T F 93 98 92
6674001 chr15:48073503 T > C N2767S 4 of 122,914 F 50 42 31
6005001 chr15:48703201 C > T 2868I M 55 91 95
SMAD3
6234001 chr15:67457343 T > C M1T M 80 75 97
6281001 chr15:67473717 C > A S161* F 70 97 78
†NA = not available andVUS= variant of unknownsigniﬁcance.‡The values are given in degrees. §The values are given in percentiles. #The values
are the scores, given in points. **The aorta was dilated on an echocardiogram.
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tomutations in TGFBR1) and type-II Loeys-Dietz syndrome (due
to mutations in TGFBR2) that have a high rate of associated
abnormalities such as biﬁd uvula and hypertelorism10, facial
dysmorphism occurs in <50% of all patients with SMAD3 mu-
tations15, making type-III Loeys-Dietz syndrome more difﬁcult to
diagnose. However, screening patients with adolescent idiopathic







and Echocardiogram** Interpretation Reference
NA NA N VUS
1 1 N VUS
3 0 N VUS
NA NA N VUS
3 0 Y VUS
1 1 Y VUS
NA NA N VUS Single report, no details16
NA NA N VUS
3 1 N VUS Patient with aortic dilation, skeletal features, and
ectopia lentis31, patient with isolated ectopia lentis32
3 3 N VUS
2 4 Y VUS Single report, no details16
NA NA N VUS Two patients with isolated aortic aneurysm17,21
4 1 Y VUS Two patients with isolated aortic aneurysm17,21
5 4 Y VUS Two patients with isolated aortic aneurysm17,21
4 0 N VUS
5 2 Y VUS
10 2 Y** Pathogenic Patients with Marfan syndrome16-18
5 2 N VUS Single report, no details16
6 9 Y VUS
NA NA Y Pathogenic
NA NA N Pathogenic
TABLE II (continued)
TABLE III Clinical Characteristics of Adolescent Idiopathic Scoliosis Cases with Rare Variants in FBN1
No Variant (N = 328) FBN1 Variant (N = 15*) P Value
Female patients† 277 (84%) 13 (87%) 1
Spinal curve‡ 55 ± 16 72 ± 20 1.1 · 1024
Height percentile‡ 46 ± 30§ 60 ± 32 0.15
Weight percentile‡ 57 ± 31§ 56 ± 32 1
First-degree relative with treated adolescent idiopathic
scoliosis†
44 (13%) 2 (13%) 1
Ghent systemic features score‡ (points) 2.6 ± 1.7# 4.0 ± 2.2** 5.3 · 1023
Beighton joint hypermobility score‡ (points) 1.5 ± 1.7†† 2.5 ± 2.4** 0.05
*One patient had two mutations. †The values are given as the number of patients, with the percentage in parentheses. ‡The values are given as
the mean and the standard deviation. §The values are based on 217 patients. #The values are based on 205 patients. **The values are based on
twelve patients. ††The values are based on 204 patients.
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Marfan syndrome was diagnosed in one patient with ado-
lescent idiopathic scoliosis after genetic evaluation in this study. In
the absence of a family history, the diagnosis of Marfan syndrome
often requires examination by a clinical geneticist, slit-lamp ex-
amination for ectopia lentis, and echocardiogram evaluation for
aortic enlargement to fulﬁll the revised Ghent diagnostic criteria2.
Notably, our patient with adolescent idiopathic scoliosis who was
subsequently diagnosed with Marfan syndrome had an elevated
Ghent systemic feature score. Although systemic features are
not routinely evaluated in orthopaedic clinics, Sponseller et al.
described several individual features, including thumb and wrist
signs, craniofacial features, pectus excavatum, severe hindfoot
valgus, dural ectasia, or acetabular protrusio that may be high-
yield features for screening23.
In the current study, 5% of our adolescent idiopathic scoli-
osis population had gene variants of unknown signiﬁcance in
FBN1 or COL3A1. Even though several FBN1 variants were
present inMarfan syndrome diseasemutation databases, not all
variants in these databases have been conclusively established
as pathogenic with use of new diagnostic criteria24. To avoid
Marfan syndrome misdiagnosis, revised Ghent clinical criteria
weigh heavily on aortic root dilation or aneurysm, ectopia
lentis, FBN1 mutation, and family history of Marfan syn-
drome2,3. Therefore, expensive additional testing would be re-
quired for these patients with adolescent idiopathic scoliosis. In
our study, the majority of adolescent idiopathic scoliosis cases
with FBN1 variants of unknown signiﬁcance who underwent
genetic evaluation and echocardiography did not meet criteria
for Marfan syndrome; therefore, we believe that FBN1 rare
variants in adolescent idiopathic scoliosis may contribute to a
primary skeletal phenotype that is characterized by increased
spinal curve severity and tall stature25.
One limitation of the current study was that clinical ge-
netics evaluations and echocardiograms were obtained in only
nine of twenty cases. Furthermore, these examinations were done
at an age when aortic root dilation may not yet be present. There-
fore, longitudinal follow-up of larger numbers of patients with ado-
lescent idiopathic scoliosis and their relatives is needed to better
understand any long-term risk. Our genetic study also evaluated
only a small subset of connective tissue disease genes, and therefore
it is possible that our patients with adolescent idiopathic scoliosis
may havemutations in other genes that were not studied that would
put them at risk for other complications. Finally, the results of this
study may not be applicable to all scoliosis cohorts, as our research
protocol excluded patients in whom connective tissue disorders
were suspect; therefore, the numbers of patients with patho-
genic variants may be much larger in an unselected population.
Genetic screening can be compared with radiographic
screening of patients with adolescent idiopathic scoliosis for
anatomic abnormalities such as Chiari malformation, syrinx, or
a tethered cord that likewise alter patient management. Overall,
the yield is similar, with 5% to 10% of patients with adolescent
idiopathic scoliosis having central nervous system abnormalities
on spinal magnetic resonance imaging26,27 compared with ;6%
of patients with adolescent idiopathic scoliosis having patho-
genic gene variants or variants of unknown signiﬁcance in the
current study. The cost of genetic testing and imaging studies
is also similar. Unfortunately, imaging and genetic screening
studies both yield large numbers of variants or lesions of un-
known signiﬁcance that lead to additional testing. For example,
most syrinxes and Chiari I malformations found on screening
examinations in asymptomatic patients with adolescent idio-
pathic scoliosis do not warrant intervention yet are often referred
for serial evaluations and imaging. In both cases, screening tests
increase the cost of health care through additional medical
testing andmay contribute to psychological stress in cases where
the clinical importance remains unknown.
The utility and cost-effectiveness of genetic screening
studies are likely to improve as data are generated to allow vari-
ants of unknown signiﬁcance to be more conﬁdently classiﬁed as
either pathogenic or benign. First, sequencing of larger numbers
of population controls, beyond the 66,000 currently available
in the ExAC database19, will better reveal the frequencies of vari-
ants in a general population, which is useful as variants that occur
at frequencies above the disease prevalence are unlikely to be
pathogenic. Second, sequencing patients with isolated skeletal
phenotypes may expand the range of phenotypes associated with
human disease mutations and may avoid publication bias in-
herent when all cases are selected from cardiology clinics. Re-
search studies should include the plan to recontact and to study
patients with these variants in greater depth. Finally, data cura-
tion in publicly available databases is essential to improve uni-
versal access and variant interpretation.
In summary, screening patients with adolescent idio-
pathic scoliosis for mutations in ﬁve clinically actionable genes
associated with aortic aneurysm revealed pathogenic mutations
in a small number of patients but resulted in diagnostically
uncertain results in 5% of those screened. Universal genetic
screening of these ﬁve genes in a general adolescent idiopathic
scoliosis population may eventually play a role in clinical care,
but the large number of variants of unknown signiﬁcance
reduces its current clinical utility. In the meantime, referral of
patients with family history of aortic aneurysm or dissection,
or clinical examination ﬁndings supportive of Marfan syn-
drome, Loeys-Dietz syndrome, or Ehlers-Danlos syndrome,
is warranted. n
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